ArticleCardiovascular therapeutics2026
Postoperative Atrial Fibrillation Impacted by Completeness of Coronary Revascularization and Antiplatelet Regimen.
Article in Cardiovascular therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Postoperative atrial fibrillation (POAF) is a common complication after off-pump coronary artery bypass grafting (OPCABG) and contributes to increased morbidity and prolonged hospital stays. Both myocardial ischemia and systemic inflammation play a critical role in its pathogenesis, which is closely related to the intensity of coronary revascularization and antiplatelet treatment, respectively. Methods: This study investigated the impact of the interaction between completeness of coronary revascularization and antiplatelet regimen on POAF incidence. Results: A total of 505 eligible patients, undergoing elective first-time OPCABG surgery from May 2017 to May 2024, were reviewed and divided into the incomplete revascularization (IR) group ( Conclusion: IR was associated with a higher rate of POAF after OPCABG in patients receiving clopidogrel-based DAPT, but not in those receiving ticagrelor-based DAPT.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.